vs
Side-by-side financial comparison of CSP INC (CSPI) and ROCKWELL MEDICAL, INC. (RMTI). Click either name above to swap in a different company.
ROCKWELL MEDICAL, INC. is the larger business by last-quarter revenue ($18.3M vs $12.0M, roughly 1.5× CSP INC). CSP INC runs the higher net margin — 0.8% vs -3.0%, a 3.8% gap on every dollar of revenue. On growth, CSP INC posted the faster year-over-year revenue change (-23.2% vs -25.6%). ROCKWELL MEDICAL, INC. produced more free cash flow last quarter ($2.2M vs $-3.0M). Over the past eight quarters, CSP INC's revenue compounded faster (-6.3% CAGR vs -10.1%).
CSP Inc. is a U.S.-based technology firm offering cybersecurity solutions, managed IT services, high-performance computing systems, and IT consulting support. It serves enterprises across healthcare, finance, manufacturing, and public sectors in North America and select global markets.
Rockwell Medical Inc. is a publicly traded pharmaceutical company based in Wixom, Michigan and founded in 1996 that focuses on development and commercialization of treatments against diseases such as end-stage renal disease (ESRD) and chronic kidney disease (CKD).
CSPI vs RMTI — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $12.0M | $18.3M |
| Net Profit | $91.0K | $-554.0K |
| Gross Margin | 39.3% | 21.1% |
| Operating Margin | -0.9% | -2.2% |
| Net Margin | 0.8% | -3.0% |
| Revenue YoY | -23.2% | -25.6% |
| Net Profit YoY | -80.7% | 26.7% |
| EPS (diluted) | $0.01 | $-0.01 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $12.0M | $18.3M | ||
| Q3 25 | $14.5M | $15.9M | ||
| Q2 25 | $15.4M | $16.1M | ||
| Q1 25 | $13.1M | $18.9M | ||
| Q4 24 | $15.7M | $24.7M | ||
| Q3 24 | $13.0M | $28.3M | ||
| Q2 24 | $13.1M | $25.8M | ||
| Q1 24 | $13.7M | $22.7M |
| Q4 25 | $91.0K | $-554.0K | ||
| Q3 25 | $-191.0K | $-1.8M | ||
| Q2 25 | $-264.0K | $-1.5M | ||
| Q1 25 | $-108.0K | $-1.5M | ||
| Q4 24 | $472.0K | $-756.0K | ||
| Q3 24 | $-1.7M | $1.7M | ||
| Q2 24 | $-185.0K | $343.0K | ||
| Q1 24 | $1.6M | $-1.7M |
| Q4 25 | 39.3% | 21.1% | ||
| Q3 25 | 36.6% | 14.3% | ||
| Q2 25 | 28.8% | 15.6% | ||
| Q1 25 | 32.0% | 16.1% | ||
| Q4 24 | 29.1% | 14.7% | ||
| Q3 24 | 28.4% | 22.0% | ||
| Q2 24 | 35.0% | 17.6% | ||
| Q1 24 | 47.3% | 13.5% |
| Q4 25 | -0.9% | -2.2% | ||
| Q3 25 | -3.7% | -9.9% | ||
| Q2 25 | -7.9% | -8.4% | ||
| Q1 25 | -7.6% | -7.2% | ||
| Q4 24 | -2.3% | -2.1% | ||
| Q3 24 | -15.7% | 6.8% | ||
| Q2 24 | -5.5% | 2.0% | ||
| Q1 24 | 9.0% | -5.8% |
| Q4 25 | 0.8% | -3.0% | ||
| Q3 25 | -1.3% | -11.0% | ||
| Q2 25 | -1.7% | -9.3% | ||
| Q1 25 | -0.8% | -8.0% | ||
| Q4 24 | 3.0% | -3.1% | ||
| Q3 24 | -12.7% | 5.9% | ||
| Q2 24 | -1.4% | 1.3% | ||
| Q1 24 | 11.6% | -7.6% |
| Q4 25 | $0.01 | $-0.01 | ||
| Q3 25 | $-0.02 | $-0.05 | ||
| Q2 25 | $-0.03 | $-0.05 | ||
| Q1 25 | $-0.01 | $-0.04 | ||
| Q4 24 | $0.05 | $-0.02 | ||
| Q3 24 | $-0.17 | $0.04 | ||
| Q2 24 | $-0.02 | $0.01 | ||
| Q1 24 | $0.16 | $-0.06 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $24.9M | $10.7M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $44.8M | $37.0M |
| Total Assets | $69.2M | $57.1M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $24.9M | $10.7M | ||
| Q3 25 | $27.4M | $13.6M | ||
| Q2 25 | $26.3M | $12.5M | ||
| Q1 25 | $29.5M | $11.4M | ||
| Q4 24 | $30.7M | $15.7M | ||
| Q3 24 | $30.6M | $12.3M | ||
| Q2 24 | $28.9M | $11.9M | ||
| Q1 24 | $27.1M | $6.6M |
| Q4 25 | $44.8M | $37.0M | ||
| Q3 25 | $44.6M | $37.0M | ||
| Q2 25 | $47.5M | $30.4M | ||
| Q1 25 | $47.5M | $31.5M | ||
| Q4 24 | $47.5M | $32.6M | ||
| Q3 24 | $47.3M | $29.1M | ||
| Q2 24 | $48.1M | $23.5M | ||
| Q1 24 | $48.2M | $20.6M |
| Q4 25 | $69.2M | $57.1M | ||
| Q3 25 | $71.2M | $57.5M | ||
| Q2 25 | $66.8M | $52.6M | ||
| Q1 25 | $67.1M | $54.0M | ||
| Q4 24 | $67.5M | $59.2M | ||
| Q3 24 | $69.4M | $57.1M | ||
| Q2 24 | $66.8M | $53.0M | ||
| Q1 24 | $64.2M | $50.7M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-2.9M | $2.3M |
| Free Cash FlowOCF − Capex | $-3.0M | $2.2M |
| FCF MarginFCF / Revenue | -25.1% | 12.0% |
| Capex IntensityCapex / Revenue | 0.9% | 0.5% |
| Cash ConversionOCF / Net Profit | -32.04× | — |
| TTM Free Cash FlowTrailing 4 quarters | $-2.8M | $-1.2M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-2.9M | $2.3M | ||
| Q3 25 | $1.9M | $-1.3M | ||
| Q2 25 | $-3.3M | $1.8M | ||
| Q1 25 | $1.9M | $-3.5M | ||
| Q4 24 | $1.7M | $865.0K | ||
| Q3 24 | $-1.5M | $4.3M | ||
| Q2 24 | $2.4M | $1.4M | ||
| Q1 24 | $1.7M | $-2.4M |
| Q4 25 | $-3.0M | $2.2M | ||
| Q3 25 | $1.7M | $-1.5M | ||
| Q2 25 | $-3.3M | $1.7M | ||
| Q1 25 | $1.9M | $-3.5M | ||
| Q4 24 | $1.7M | $470.0K | ||
| Q3 24 | $-1.5M | $4.1M | ||
| Q2 24 | $2.4M | $1.2M | ||
| Q1 24 | $1.6M | $-2.5M |
| Q4 25 | -25.1% | 12.0% | ||
| Q3 25 | 11.5% | -9.6% | ||
| Q2 25 | -21.7% | 10.5% | ||
| Q1 25 | 14.5% | -18.8% | ||
| Q4 24 | 10.8% | 1.9% | ||
| Q3 24 | -11.7% | 14.4% | ||
| Q2 24 | 17.9% | 4.5% | ||
| Q1 24 | 11.9% | -11.1% |
| Q4 25 | 0.9% | 0.5% | ||
| Q3 25 | 1.6% | 1.4% | ||
| Q2 25 | 0.4% | 1.0% | ||
| Q1 25 | 0.1% | 0.3% | ||
| Q4 24 | 0.3% | 1.6% | ||
| Q3 24 | 0.1% | 0.7% | ||
| Q2 24 | 0.3% | 1.1% | ||
| Q1 24 | 0.1% | 0.6% |
| Q4 25 | -32.04× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 3.69× | — | ||
| Q3 24 | — | 2.57× | ||
| Q2 24 | — | 4.20× | ||
| Q1 24 | 1.04× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CSPI
| Products | $6.7M | 56% |
| Services | $5.3M | 44% |
RMTI
| US | $15.9M | 87% |
| Non Us | $2.4M | 13% |
